Table 5 Characteristics of obese with diabetes participants before and after exercise (n = 27).
From: Spexin as an indicator of beneficial effects of exercise in human obesity and diabetes
Obese with diabetes (pre) | Obese with diabetes (post) | Variation | P values | |
|---|---|---|---|---|
BMI (kg/m2) | 33.8 ± 2.4 | 33.1 ± 3.6 | − 0.71 ± 0.59 | 0.356 |
Waist (cm) | 111.8 ± 5.1 | 109.5 ± 5.8 | − 2.32 ± 2.13 | 0.115 |
Hip (cm) | 113.5 ± 6.1 | 113.5 ± 5.6 | − 0.01 ± 0.19 | 0.988 |
PBF (%) | 38.3 ± 5.1 | 36.1 ± 5.3 | − 2.18 ± 1.56 | 0.055 |
WBC10 | 7.6 ± 1.3 | 7.4 ± 1.8 | − 0.23 ± 0.09 | 0.622 |
SBP (mmHg) | 122.2 ± 13.0 | 122.6 ± 8.6 | 0.41 ± 1.38 | 0.908 |
DBP (mmHg) | 76.7 ± 5.0 | 75.8 ± 5.7 | − 0.89 ± 0.47 | 0.769 |
Resting HR (beats/min) | 86.0 ± 7.0 | 78.0 ± 11.7 | − 8.01 ± 6.83 | 0.042 |
VO2, max (ml/kg/min) | 16.7 ± 4.2 | 20.1 ± 4.9 | 3.41 ± 3.89 | 0.173 |
TC (mmol/l) | 4.8 ± 1.1 | 4.4 ± 0.9 | − 0.38 ± 0.29 | 0.041 |
HDL (mmol/l) | 1.1 ± 0.3 | 1.0 ± 0.3 | − 0.07 ± 0.17 | 0.165 |
LDL (mmol/l) | 2.9 ± 1.1 | 2.8 ± 0.9 | − 0.11 ± 0.24 | 0.702 |
TG (mmol/l) | 1.7 ± 0.5 | 1.6 ± 0.8 | − 0.09 ± 0.28 | 0.799 |
FBG (mmol/l) | 8.6 ± 3.4 | 8.2 ± 3.2 | − 0.41 ± 0.88 | 0.515 |
HbA1c (%) | 8.2 ± 2.0 | 7.3 ± 1.3 | − 0.85 ± 0.63 | < 0.001 |
Insulin (ng/ml) | 4.0 ± 2.0 | 3.7 ± 2.4 | − 0.26 ± 0.49 | 0.521 |
C-peptide (ng/ml) | 4.4 ± 6.0 | 4.1 ± 3.8 | − 0.30 ± 0.14 | 0.681 |
HOMA-IR | 1.6 ± 0.9 | 1.4 ± 0.8 | − 0.21 ± 0.37 | 0.245 |
hsCRP (μg/ml) | 5.3 ± 2.3 | 6.1 ± 3.9 | 0.81 ± 0.1.32 | 0.493 |
